泰康在线“好效保·癌症复发险”系列获评2025年度值得关注健康险产品

Core Insights - The article highlights the significant progress in cancer prevention and treatment in China under the "Healthy China 2030" strategy, while also addressing the high medical expenses faced by families after cancer recurrence [1] - The government encourages innovation in commercial health insurance products, positioning them as an important component of the multi-tiered medical security system [1] Group 1: Product Innovation - Taikang Online has proactively entered the critical illness insurance market with its "Good Effect Insurance: Cancer Recurrence Insurance" series, which fills a market gap and provides essential economic and psychological support to families [1] - The series includes targeted products for various types of cancer, such as breast cancer, thyroid cancer, lung cancer, colorectal cancer, and lymphoma, ensuring comprehensive coverage for high-incidence and high-burden cancers [4] Group 2: Medical Integration - The "Good Effect Insurance: Cancer Recurrence Insurance" series transcends traditional compensation models by integrating medical and pharmaceutical resources, creating a complete support system for patients [5] - The latest iteration of the breast cancer recurrence insurance, "Pink Guardian," addresses the accessibility of innovative drugs and includes a dual protection system of reimbursement and payment, covering all aspects from hospitalization to outpatient care [5] Group 3: Advanced Treatment Coverage - The lymphoma recurrence insurance, "Green Guardian," incorporates cutting-edge therapies such as bispecific antibody therapy and CAR-T cell therapy, significantly lowering the financial barriers for patients undergoing advanced treatments [6] Group 4: Commitment to Service - Taikang Online emphasizes its commitment to serving the public by leveraging its extensive medical and care ecosystem, along with advanced technology for risk management and customer service [7] - The recognition received for the "2025 Annual Noteworthy Health Insurance Product" underscores the company's expertise and dedication in the field of critical illness insurance [7]